艾滋病疫苗 z-bo 2020-09-17 364

　　The sponsor of the biological trial of Beijing Yuan Hospital and Professor Yiming Shao of the Chinese Center for Disease Control jointly developed the domestic AIDS vaccine clinical trial project of Beijing Yuan Hospital. Currently, Tendan Biologics and Beijing Biologicsesearch Institute belong to the same organization, namely China Biotechnology Co., Ltd., a subsidiary of China National Pharmaceutical Group. In July 2013, Li Ning, director of Beijing You'an Hospital, said: "China's proprietary AIDS vaccine trial has entered the clinical stage. If the trial is successful, it is expected to start within six years."

　　"The AIDS vaccine projects currently announced in China include Shao Yiming’s team, Changchun’s high-tech subsidiary Baike Pharmaceuticals and Aoke Bio. According to the information provided, the AIDS vaccine is currently in phase II clinical trials and has not been updated so far. Biological therapeutic genetic engineering AIDS vaccine progress. Wu Zunyou, head of the AIDS Prevention and Management Center, said in an online interview hosted by the National Health and Family Planning Commission yesterday (1st) that according to the 2014 Global AIDS Report, he Survived worldwide in 2013. In that year, the number of HIV-infected people and patients was 35 million, the number of new HIV infections was approximately 2.1 million, the death toll was 1.5 million, and 75 of the 35 million people in the world were infected. % Is 15 China is concentrated in one country. It is one of the 15 countries and definitely one of the most severely infected countries with HIV.